Cervical Interbody Fusion Device Patient Registry

Sponsor
Restor3D (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05114356
Collaborator
(none)
100
1
13.7
7.3

Study Details

Study Description

Brief Summary

The registry has been designed as a prospective, observational program for patients undergoing anterior cervical discectomy and fusion (ACDF) procedures treated with TIDAL cervical interbody fusion device. The ultimate goal of the study is to aid in the development of treatment pathways and improved patient care. All patients who agree to participate in the registry will sign an informed consent form and subsequently be treated by their surgeon with the device in either an inpatient or outpatient facility.

Condition or Disease Intervention/Treatment Phase
  • Device: TIDAL Cervical Interbody Fusion implant

Detailed Description

The registry is design to collect data prospectively on patients undergoing spinal fusion using the TIDAL cervical interbody fusion device. Patients will be enrolled in the registry after reviewing the protocol with their health care provider and signing the informed consent. Data will be collected at recommended time points based on the standards of care of the participating sites. The registry will serve as a database in which retrospective analysis and exploratory analysis of specific research questions will be answered.

Follow up visits will be defined by the treating physicians based on their standard practice. Typical clinical follow up schedules for patients undergoing this type of surgery are pre-operative and 12 months post-operative.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Cervical Interbody Fusion Device Patient Registry
Actual Study Start Date :
Nov 8, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Study group

Patients being treated for degenerative disc disease

Device: TIDAL Cervical Interbody Fusion implant
Cervical interbody fusion device

Outcome Measures

Primary Outcome Measures

  1. Change in Oswestry Disability Index (ODI)/Neck Disability Index (NDI) Score Range 0-50 at 1 year post-operative from a pre-operative baseline [1 year]

    ODI/NDI Score Range: 0-50 0-4 No disability 5-14 Mild disability 15-24 Moderate disability 25-34 Severe disability >34 Complete disability

  2. Change in VAS Pain at 1 year post-operative from a pre-operative baseline [1 year]

    VAS PAIN SEVERITY SCALE ranges from 0-10. A score of zero (0) means 'no pain' and a ten (10) means 'worst imaginable pain'

Secondary Outcome Measures

  1. Improvement in patient reported short-form 36 (SF36) scores at 1 year post-operative from a pre-operative baseline [1 year]

    Questionnaire of generic, coherent, and easily administered quality-of-life measures.

  2. Rate of Successful Fusion Based on Radiological Assessment at 1 Year Post-op [1 year]

    Assessment of fusion

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Neck and arm pain for a minimum of 6 weeks before surgery that is recalcitrant to nonoperative treatment modalities, such as physical therapy, reduced activities, and anti-inflammatory medications.

  • Radiographic evidence of cervical disc disease that is documented on dynamic radiographs and magnetic resonance imaging (MRI).

Exclusion Criteria:
  • Medical condition that required medication, such as steroids or nonsteroidal anti-inflammatory medications, that could interfere with fusion.

There are no restrictions on sex or ethnicity.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Orthopaedic Institute of Western Kentucky Paducah Kentucky United States 42001

Sponsors and Collaborators

  • Restor3D

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Restor3D
ClinicalTrials.gov Identifier:
NCT05114356
Other Study ID Numbers:
  • restor3d-001
First Posted:
Nov 10, 2021
Last Update Posted:
Jun 3, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 3, 2022